GSK announced that Sir Philip Hampton has been appointed as Chairman of the Nominations Committee with effect from Jan. 27, 2015, replacing Sir Christopher Gent, who will continue to serve as a member of the Committee for the remainder of his tenure on the Board. In addition, Ms. Lynn Elsenhans has also been appointed a member of the Committee, effective Jan.

27, 2015.